annual EBIT:
-$285.42M-$112.55M(-65.11%)Summary
- As of today (September 16, 2025), AKRO annual earnings before interest & taxes is -$285.42 million, with the most recent change of -$112.55 million (-65.11%) on December 31, 2024.
- During the last 3 years, AKRO annual EBIT has fallen by -$184.54 million (-182.92%).
- AKRO annual EBIT is now -6153.79% below its all-time high of -$4.56 million, reached on December 31, 2017.
Performance
AKRO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$80.87M+$9000.00(+0.01%)Summary
- As of today (September 16, 2025), AKRO quarterly earnings before interest & taxes is -$80.87 million, with the most recent change of +$9000.00 (+0.01%) on June 30, 2025.
- Over the past year, AKRO quarterly EBIT has dropped by -$15.13 million (-23.02%).
- AKRO quarterly EBIT is now -19109.74% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$321.48M-$15.13M(-4.94%)Summary
- As of today (September 16, 2025), AKRO TTM earnings before interest & taxes is -$321.48 million, with the most recent change of -$15.13 million (-4.94%) on June 30, 2025.
- Over the past year, AKRO TTM EBIT has dropped by -$87.30 million (-37.28%).
- AKRO TTM EBIT is now -58887.71% below its all-time high of -$545.00 thousand, reached on December 1, 2017.
Performance
AKRO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AKRO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.1% | -23.0% | -37.3% |
| 3 y3 years | -182.9% | -193.1% | -191.1% |
| 5 y5 years | -525.6% | -391.5% | -424.1% |
AKRO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -182.9% | at low | -218.2% | +1.0% | -191.1% | at low |
| 5 y | 5-year | -525.6% | at low | -434.6% | +1.0% | -424.1% | at low |
| alltime | all time | -6153.8% | at low | <-9999.0% | +1.0% | <-9999.0% | at low |
AKRO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$80.87M(-0.0%) | -$321.48M(+4.9%) |
| Mar 2025 | - | -$80.88M(+3.7%) | -$306.35M(+7.3%) |
| Dec 2024 | -$285.42M(+65.1%) | -$78.03M(-4.5%) | -$285.42M(+6.0%) |
| Sep 2024 | - | -$81.70M(+24.3%) | -$269.27M(+15.0%) |
| Jun 2024 | - | -$65.74M(+9.7%) | -$234.18M(+14.8%) |
| Mar 2024 | - | -$59.95M(-3.1%) | -$204.07M(+18.0%) |
| Dec 2023 | -$172.87M(+50.1%) | -$61.87M(+32.7%) | -$172.87M(+26.7%) |
| Sep 2023 | - | -$46.62M(+30.8%) | -$136.42M(+8.4%) |
| Jun 2023 | - | -$35.63M(+23.9%) | -$125.89M(+6.8%) |
| Mar 2023 | - | -$28.75M(+13.1%) | -$117.86M(+2.3%) |
| Dec 2022 | -$115.16M(+14.1%) | -$25.42M(-29.6%) | -$115.16M(-5.7%) |
| Sep 2022 | - | -$36.09M(+30.8%) | -$122.17M(+10.6%) |
| Jun 2022 | - | -$27.59M(+5.9%) | -$110.44M(-1.2%) |
| Mar 2022 | - | -$26.05M(-19.7%) | -$111.81M(+10.8%) |
| Dec 2021 | -$100.89M | -$32.44M(+33.2%) | -$100.89M(+2.7%) |
| Sep 2021 | - | -$24.35M(-15.9%) | -$98.23M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$28.97M(+91.5%) | -$95.42M(+15.1%) |
| Mar 2021 | - | -$15.13M(-49.2%) | -$82.90M(+3.4%) |
| Dec 2020 | -$80.15M(+75.7%) | -$29.78M(+38.3%) | -$80.15M(+20.4%) |
| Sep 2020 | - | -$21.54M(+30.9%) | -$66.57M(+8.5%) |
| Jun 2020 | - | -$16.45M(+32.9%) | -$61.34M(+16.8%) |
| Mar 2020 | - | -$12.38M(-23.6%) | -$52.49M(+15.1%) |
| Dec 2019 | -$45.63M(+231.2%) | -$16.20M(-0.7%) | -$45.63M(+40.8%) |
| Sep 2019 | - | -$16.31M(+114.3%) | -$32.40M(+81.8%) |
| Jun 2019 | - | -$7.61M(+38.0%) | -$17.82M(-5.6%) |
| Mar 2019 | - | -$5.51M(+85.7%) | -$18.87M(+37.0%) |
| Dec 2018 | -$13.78M(+201.9%) | -$2.97M(+71.9%) | -$13.78M(+21.3%) |
| Sep 2018 | - | -$1.73M(-80.1%) | -$11.36M(+17.9%) |
| Jun 2018 | - | -$8.66M(+1957.5%) | -$9.63M(+896.7%) |
| Mar 2018 | - | -$421.00K(-22.8%) | -$966.00K(+77.2%) |
| Dec 2017 | -$4.56M | - | - |
| Dec 2017 | - | -$545.00K | -$545.00K |
FAQ
- What is Akero Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual EBIT year-on-year change?
- What is Akero Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Akero Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM EBIT year-on-year change?
What is Akero Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AKRO is -$285.42M
What is the all time high annual EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$4.56M
What is Akero Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AKRO annual earnings before interest & taxes has changed by -$112.55M (-65.11%)
What is Akero Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AKRO is -$80.87M
What is the all time high quarterly EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$421.00K
What is Akero Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AKRO quarterly earnings before interest & taxes has changed by -$15.13M (-23.02%)
What is Akero Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AKRO is -$321.48M
What is the all time high TTM EBIT for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$545.00K
What is Akero Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AKRO TTM earnings before interest & taxes has changed by -$87.30M (-37.28%)